Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
Authors
Keywords
Human papillomavirus, Nonavalent vaccine, Bivalent vaccine, Cervical cancer, Cost-effectiveness, Transmission dynamic model
Journal
VACCINE
Volume 39, Issue 16, Pages 2255-2263
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.vaccine.2021.03.040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis
- (2020) Didik Setiawan et al. PLoS One
- Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
- (2020) Rashidul Alam Mahumud et al. PLoS One
- Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
- (2018) Kine Pedersen et al. EUROPEAN JOURNAL OF CANCER
- Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
- (2018) Horace C. W. Choi et al. BMC Medicine
- Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
- (2017) C. SIGNORELLI et al. EPIDEMIOLOGY AND INFECTION
- 4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years
- (2017) Daron G. Ferris et al. PEDIATRICS
- Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage
- (2017) Triin Võrno et al. VACCINE
- Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
- (2016) L. Boiron et al. BMC INFECTIOUS DISEASES
- Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine
- (2016) Harrell W. Chesson et al. JOURNAL OF INFECTIOUS DISEASES
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Response to Editorial: Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report
- (2016) VALUE IN HEALTH
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States
- (2015) Marc Brisson et al. JNCI-Journal of the National Cancer Institute
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States
- (2015) Marc Brisson et al. JNCI-Journal of the National Cancer Institute
- Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
- (2013) Mélanie Drolet et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia
- (2012) Swee Chong Quek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Epidemiologic risk profile of infection with different groups of human papillomaviruses
- (2009) Paul K.S. Chan et al. JOURNAL OF MEDICAL VIROLOGY
- Health and Economic Implications of HPV Vaccination in the United States
- (2008) Jane J. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now